The Alzheimer’s Drug Discovery Foundation (ADDF) announced that a Georgetown University Medical Center researcher has been awarded a $2.1 million grant to conduct a Phase 2 clinical trial of low-dose nilotinib (Tasigna, a cancer therapy) in patients with Alzheimer’s disease. The grant was awarded as part of the ADDF’s…
UsAgainstAlzheimer’s hosted the 2016 National Alzheimer’s Summit on Sept. 27–29, bringing together members of the U.S. Congress, scientific researchers, industry leaders, and people living with Alzheimer’s disease (AD) to press for greater investment in Alzheimer’s research, improvements in healthcare, and greater efforts to ease socioeconomic and cultural…
The Association for Frontotemporal Degeneration (AFTD) is hosting its inaugural Hope Rising Benefit Sept. 29, to increase awareness of frontotemporal degeneration (FTD) and raise funds to support AFTD’s collaborative research, education for healthcare professionals and advocacy for affordable services. FTD is a disease process that damages the temporal…
September 21 was World Alzheimer’s Day, a fitting occasion to announce that a recent study from Finnish and Swedish researchers has confirmed that MedUni Vienna scientists were right: Multimodal everyday training does, indeed, have a beneficial effect upon cognitive abilities such as planning and implementing projects. That is true for…
Cure Alzheimer’s Fund recently announced that it has awarded over $6 million in research grants this year to support scientific projects working to improve our knowledge of Alzheimer’s disease (AD) and to develop potential treatments. In total in 2016, so far, the organization has funded 29 projects in the U.S. and…
Researchers at the University of British Columbia (UBC) have found that many online resources about how to prevent Alzheimer’s disease (AD) are not accurate and can mislead readers. In a survey of online resources, UBC researchers found that a series of websites offered poor advice and one in five was…
The U.S. Food and Drug Administration (FDA) issued a draft guidance in 2013 to encourage research in people at the earliest stages of Alzheimer’s disease, with no symptoms or no obvious symptoms. The update has had effect, with new clinical trials looking at Alzheimer’s patients without noticeable dementia, when they…
The National Institutes of Health’s recent $40 million award over the next five years will provide a new stage of research for the Alzheimer’s Disease Neuroimaging Initiative (ADNI), an NIH public-private partnership. The ADNI is supported by the Foundation for the National Institutes of Health (FNIH), which anticipates $20…
The rate of Alzheimer’s disease (AD) is increasing worldwide with the most significant risk factors appearing to be associated with diet, particularly the consumption of sweets, meat, and high-fat dairy products common in the Western diet, according to a new study report. For example, during Japan’s transition from the Japanese diet to the…
New York City’s Alzheimer’s and dementia expert organization, CaringKind, announced the recent appointment of Niurqui “Nikki” Mariano as its new manager of healthcare outreach. CaringKind, previously known as the New York City chapter of the Alzheimer’s Association, has over three decades of experience in working with dementia and Alzheimer’s…
Get regular updates to your inbox.